Ucyclyd's main product was Buphenyl (sodium phenylbutyrate), used for treating urea cycle disorders.

[8] For the year, Medicis recorded $721 million in revenue with a gross profit margin of roughly 90 percent.

[1] The company's founder, Jonah Shacknai, came to media attention in 2011 due to investigations into the deaths of his son Max and girlfriend Rebecca Zahau.

A jury in a 2018 civil trial concluded that the death of Zahau a homicide by Jonah's brother, Adam Shacknai.

[13] The transaction was completed in December 2012, with Medicis delisting and becoming a subsidiary of Valeant, after which its board of directors disbanded.